NURS 329 COMPREHENSIVE
CERTIFICATION SCRIPT 2026 QUESTIONS
WITH ANSWERS GRADED A+
⩥ Which of the following drugs has no anti-inflammatory properties
and blocks transmission of pain impulses peripherally?
A. Acetaminophen (Tylenol)
B. Aspirin (ASA)
C. Tramadol (Ultram)
D. All of the above. Answer: A. Acetaminophen (Tylenol)
⩥ The nurse is caring for a patient with anemia related to chronic
renal failure. Which agent might be used to treat the anemia?
a. Filgrastim [Neupogen]
b. Sargramostim [Leukine]
c. Oprelvekin [Neumega]
d. Epoetin alfa [Procrit]. Answer: d. Epoetin alfa [Procrit]
⩥ The nurse is administering epoetin alfa [Procrit] to a patient
receiving chemotherapy. Which adverse effect is a potential risk with
this drug?
,a. Accelerated tumor progression
b. Hypotension
c. Easy bruising
d. Bone pain. Answer: a. Accelerated tumor progression
⩥ The nurse is caring for a patient undergoing cancer chemotherapy
who presents with rash, bone pain, hypertension, and pedal edema.
Which symptom is most likely an adverse reaction to the filgrastim
[Neupogen] the patient is receiving?
a. Rash
b. Bone pain
c. Headache
d. Swelling in feet. Answer: b. Bone pain
⩥ The nurse is evaluating the effectiveness of the drug oprelvekin
[Neumega] in a patient undergoing cancer chemotherapy. Which
finding is most indicative that this drug is having its intended effect?
a. Platelet count of 150 × 103/mm3
b. Hemoglobin level of 13.2 g/dL
c. White blood cell count of 5500/mm3
,d. Total lymphocyte count of 1000/mm3. Answer: a. Platelet count of
150 × 103/mm3
⩥ Which finding indicates a positive outcome from treatment with
filgrastim [Neupogen]?
a. Bone pain is eliminated.
b. The neutrophil count increases.
c. Cancer goes into remission.
d. The red blood cell count increases.. Answer: b. The neutrophil
count increases.
⩥ The healthcare provider prescribes hematopoietic growth factor for
a patient. The nurse should notify the healthcare provider to question
the prescription for which patient condition?
a. A patient with chronic renal failure (CRF)
b. A patient with uncontrolled hypertension
c. A patient taking zidovudine for human immunodeficiency virus
(HIV)
d. A patient with nonmyeloid malignancy chemotherapy-induced
anemia. Answer: b. A patient with uncontrolled hypertension
, ⩥ A patient with nonmyeloid cancer is receiving oprelvekin
[Neumega]. Which adverse effects are most likely associated with this
drug? (Select all that apply.)
a. Hypertension
b. Accelerated tumor progression
c. Fluid retention
d. Atrial fibrillation
e. Anaphylactic reactions. Answer: c, d, and e
⩥ The nurse should review which baseline data before starting
epoetin alfa [Epogen] therapy in a patient with chronic renal failure
(CRF)? (Select all that apply.)
a. Ferritin level
b. Temperature trends
c. Blood glucose level
d. Blood pressure trends
e. Hemoglobin and hematocrit. Answer: a, d, and e
⩥ A transplant recipient is receiving cyclosporine [Sandimmune].
Which response should a nurse expect if the medication is having the
desired effect?
CERTIFICATION SCRIPT 2026 QUESTIONS
WITH ANSWERS GRADED A+
⩥ Which of the following drugs has no anti-inflammatory properties
and blocks transmission of pain impulses peripherally?
A. Acetaminophen (Tylenol)
B. Aspirin (ASA)
C. Tramadol (Ultram)
D. All of the above. Answer: A. Acetaminophen (Tylenol)
⩥ The nurse is caring for a patient with anemia related to chronic
renal failure. Which agent might be used to treat the anemia?
a. Filgrastim [Neupogen]
b. Sargramostim [Leukine]
c. Oprelvekin [Neumega]
d. Epoetin alfa [Procrit]. Answer: d. Epoetin alfa [Procrit]
⩥ The nurse is administering epoetin alfa [Procrit] to a patient
receiving chemotherapy. Which adverse effect is a potential risk with
this drug?
,a. Accelerated tumor progression
b. Hypotension
c. Easy bruising
d. Bone pain. Answer: a. Accelerated tumor progression
⩥ The nurse is caring for a patient undergoing cancer chemotherapy
who presents with rash, bone pain, hypertension, and pedal edema.
Which symptom is most likely an adverse reaction to the filgrastim
[Neupogen] the patient is receiving?
a. Rash
b. Bone pain
c. Headache
d. Swelling in feet. Answer: b. Bone pain
⩥ The nurse is evaluating the effectiveness of the drug oprelvekin
[Neumega] in a patient undergoing cancer chemotherapy. Which
finding is most indicative that this drug is having its intended effect?
a. Platelet count of 150 × 103/mm3
b. Hemoglobin level of 13.2 g/dL
c. White blood cell count of 5500/mm3
,d. Total lymphocyte count of 1000/mm3. Answer: a. Platelet count of
150 × 103/mm3
⩥ Which finding indicates a positive outcome from treatment with
filgrastim [Neupogen]?
a. Bone pain is eliminated.
b. The neutrophil count increases.
c. Cancer goes into remission.
d. The red blood cell count increases.. Answer: b. The neutrophil
count increases.
⩥ The healthcare provider prescribes hematopoietic growth factor for
a patient. The nurse should notify the healthcare provider to question
the prescription for which patient condition?
a. A patient with chronic renal failure (CRF)
b. A patient with uncontrolled hypertension
c. A patient taking zidovudine for human immunodeficiency virus
(HIV)
d. A patient with nonmyeloid malignancy chemotherapy-induced
anemia. Answer: b. A patient with uncontrolled hypertension
, ⩥ A patient with nonmyeloid cancer is receiving oprelvekin
[Neumega]. Which adverse effects are most likely associated with this
drug? (Select all that apply.)
a. Hypertension
b. Accelerated tumor progression
c. Fluid retention
d. Atrial fibrillation
e. Anaphylactic reactions. Answer: c, d, and e
⩥ The nurse should review which baseline data before starting
epoetin alfa [Epogen] therapy in a patient with chronic renal failure
(CRF)? (Select all that apply.)
a. Ferritin level
b. Temperature trends
c. Blood glucose level
d. Blood pressure trends
e. Hemoglobin and hematocrit. Answer: a, d, and e
⩥ A transplant recipient is receiving cyclosporine [Sandimmune].
Which response should a nurse expect if the medication is having the
desired effect?
